Shares of EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) rose 139% during trading on Monday . The company traded as high as $0.2180 and last traded at $0.2180. Approximately 12,218 shares were traded during mid-day trading, an increase of 535% from the average daily volume of 1,924 shares. The stock had previously closed at $0.0912.
EOM Pharmaceutical Stock Performance
The stock’s 50 day simple moving average is $0.16 and its 200-day simple moving average is $0.11.
About EOM Pharmaceutical
EOM Pharmaceutical, trading under the ticker OTCMKTS:IMUC, is a clinical-stage biotechnology company focused on the development of cell-based immunotherapies for the treatment of solid tumors. The company leverages dendritic cell technology to create personalized therapeutic vaccines designed to activate a patient’s immune system against tumor-specific antigens. By harnessing key insights into antigen presentation and T-cell activation, EOM Pharmaceutical aims to improve survival outcomes for patients with cancers that currently have limited treatment options.
The company’s lead programs are directed at glioblastoma multiforme and other aggressive tumor types, where standard therapies often fall short.
Featured Stories
- Five stocks we like better than EOM Pharmaceutical
- Wall Street Stockpicker Names #1 Stock of 2026
- Your “birthright claim” just got activated
- The McDonald’s Secret
- Terrifying reason Trump killed the U.S. penny?
- Turn your “dead money” into $306+ monthly (starting this month)
Receive News & Ratings for EOM Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
